“I think in this instance we priced at a point where we can get a return, although I have to tell you that the cost of goods, the cost of manufacturing these cells and processing is very, very high.”
and there's the stumbling block. Probably will never be a widely administered therapy unless they can reduce the manufacturing cost.
News 
Market Data 
Discover 
AI
